Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001

By Andersson Michael   Jensen Maj-Britt   Engholm Gerda   Henrik Storm Hans  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 755-764

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel: As Neoadjuvant Therapy in Early-Stage or Locally Advanced Breast Cancer

By Wiseman Lynda R.   Keam Susan J.  

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 199-206

Adis International

Access to resources Recommend Favorite

Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients

By Liang Xu  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 331-334

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer

By Christensen Søren  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 339-355

Springer Publishing Company

Access to resources Recommend Favorite

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)

By Kuroi Katsumasa   Shimozuma Kojiro   Ohashi Yasuo   Hisamatsu Kazufumi   Masuda Norikazu   Takeuchi Ayano   Aranishi Toshihiko   Morita Satoshi   Ohsumi Shozo   Hausheer Frederick  

Supportive Care in Cancer, Vol. 17, Iss. 8, 2009-08 ,pp. : 1071-1080

Springer Publishing Company

Access to resources Recommend Favorite